期刊文献+

老年冠心病慢性心力衰竭患者血清NGAL与NT-proBNP的水平及临床意义 被引量:17

Serum levels of neutrophil gelatinase associated lipocalin and NT-proB NP in elderly chronic heart failure patients with coronary artery disease and their clinical significance
暂未订购
导出
摘要 目的检测老年冠心病慢性心力衰竭(CHF)患者血清中性粒细胞明胶酶相关脂质运载蛋白(NGAL)和血清N末端B型利钠肽原(NT-pro BNP)的水平变化,探讨血清NGAL水平与NT-pro BNP和肾功能指标的相关关系及其对老年冠心病CHF患者早期肾损害的诊断价值。方法测定54例老年冠心病CHF患者、30例老年冠心病心功能代偿患者和31例老年健康者血清NGAL和NT-pro BNP水平。采用Pearson相关分析得出血清NGAL水平与NT-pro BNP和肾功能指标的相关关系。应用受试者操作特征(ROC)曲线评价血清NGAL诊断早期肾损害的准确性。结果老年冠心病CHF患者血清NGAL和NT-pro BNP水平均明显高于心功能代偿患者和老年健康者,3组血清NGAL和NT-pro BNP水平两两比较差异均有统计学意义(P<0.01或P<0.05)。老年冠心病CHF患者血清NGAL水平与NT-pro BNP、Scr、BUN、Um ALB呈正相关(r值分别为0.809、0.553、0.439、0.441,P均<0.01);与估计肾小球滤过率(e GFR)呈负相关(r值为-0.563,P<0.01)。血清NGAL诊断肾功能不全的ROC曲线下面积为0.884,敏感度和特异度分别为93.5%和84.5%。结论血清NGAL是反映老年冠心病CHF患者心衰病情严重程度和诊断早期肾损害的较好指标。 Objective To test the serum levels of neutrophil gelatinase associated lipoealin (NGAL) and N-terminal pro- B-type natriuretie peptide(NT-proBNP) in elderly chronic heart failure(CHF) patients with coronary artery disease,ex- plo]ye the correlation between renal function markers and serum NGAL and NT-proBNP, and investigate the diagnostic value of serum NGAL for early impairment of renal function. Methods The levels of serum NGAL and NT-proBNP were measured in 54 elderly CHF patients with coronary artery disease, 30 elderly patients with coronary artery disease but compensated heart function and 31 elderly healthy persons. The relationship between the renal function markers and the levels of serum NGAL and NT-proBNP was analyzed by Person correlation analysis. The accuracy of serum NGAL in diag- nosing renal insufficiency was evaluated by ROC curve. Results Serum NGAL and NT-proBNP levels in CHF group was higher than that of two other groups. The difference of serum NGAL and NT-proBNP level among three groups were signifi- cant(P 〈 0.01 or P 〈 0.05 ). Pearson correlation analysis showed that serum NGAL level was positively correlated with NT-proBNP, Scr, BUN and UmALB ( r was 0.809,0. 553,0.439,0. 441, P 〈 0.01 respectively ) and was negatively corre- lated with EGFR(r was 0. 563 ,P 〈0.01 ). The area under ROC curve of serum NGAL in diagnosing renal insufficiency was 0.884. The Sensitivity and specificity was 93.5% and 84.5% respectively. Conclusion Serum NGAL was a good marker for reflecting the severity of heart failure and diagnosing early impairment of renal function in elderly CHF patients with coronary artery disease.
出处 《中华全科医学》 2015年第4期523-525,555,共4页 Chinese Journal of General Practice
基金 卫生部行业科研专项项目基金(201002011) 北京市保健科研课题项目基金(京11-13号)
关键词 中性粒细胞明胶酶相关脂质运载蛋白 N末端B型利钠肽原 心力衰竭 冠状动脉 肾功能 Neutrophil gelatinase-associated lipocalin N-terminal pro-B-type natriuretic peptide Heart failure Coronary artery Renal function
  • 相关文献

参考文献17

二级参考文献105

  • 1俞森洋.常见感染致病菌的耐药机制及防治对策[J].中国呼吸与危重监护杂志,2002,1(2):71-75. 被引量:19
  • 2俞兴群,李远思,聂卫群,高志凌,王龙梅,洪峰.呼吸机相关肺炎的危险因素和病原菌临床研究[J].安徽医学,2007,28(1):11-13. 被引量:16
  • 3吴敏,邓建平,姚春红,朱海波.大肠埃希菌及肺炎克雷伯菌产超广谱β-内酰胺酶菌株的分布及耐药性分析[J].中华医院感染学杂志,2007,17(4):455-456. 被引量:49
  • 4中华人民共和国卫生部.医院感染诊断标准[S].北京:中华人民共和国卫生部,2001:7-8.
  • 5金大鹏.北京地区医疗机构抗菌药物临床应用指南[M].上海:第二军医大学出版社,2007.
  • 6陈燕玲.预防与控制ESBLs、MRSA耐药菌的传播流行[C].2007年全国医院感染控制、消毒管理学术交流会,2007:130-105.
  • 7Kallel H, Hergafi L, Bahloul M, et al. Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study. Intensive Care Med, 2007,33 : 1162-1167.
  • 8Reina R, Estenssoro E, Saenz G, et al. Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study. Intensive Care Med,2005,31 : 1058-1065.
  • 9Rios FG, Luna CM, Maskin B, et al. Ventilator-associated pneumonia due to colistin susceptible-only microorganisms. Eur Respir J ,2007,30:307-313.
  • 10Oliveira MS, Prado GV, Costa SF, et al. Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp. J Antimicrob Chemother, 2008,61 : 1369-1375.

共引文献136

同被引文献163

  • 1马建兴,权晓莉,裴斐.冠状动脉旁路移植术前心力衰竭与术后发生急性肾功能损伤的关系[J].临床心血管病杂志,2020,36(2):120-123. 被引量:6
  • 2张曼,王文刚,曾定尹.法舒地尔对心力衰竭大鼠血流动力学和心肌细胞内钙离子浓度的影响[J].中国新药与临床杂志,2006,25(1):33-36. 被引量:17
  • 3吴以岭,谷春华,徐贵成,魏聪,高学东.芪苈强心胶囊治疗慢性心力衰竭随机双盲、多中心临床研究[J].疑难病杂志,2007,6(5):263-266. 被引量:88
  • 4无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3756
  • 5YANCY CW, JESSUP M, BOZKURT B, et al. 2013 ACCF/ AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines[J]. Circulation, 2013, 128(16) : e240-e327.
  • 6MILLER WL, GRILL DE, STRUCK J, et al. Association of hyponatremia and elevated copeptin with death and need for transplantation in ambulatory patients with chronic heart failure [J]. Am J Cardiol, 2013, 111(6): 880-885.
  • 7HRYNCHYSHYN N, JOURDAIN P, DESNOS M, et al. Galectin- 3: a new biomarker for the diagnosis, analysis and prognosis of acute and chronic heart faillure[J]. Arch Cardiovasc Dis, 2013, 106(10) : 541-546.
  • 8STOISER B, MORTL D, HULSMANN M, et al. Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure[J]. Eur J Clin Invest, 2006, 36 ( 11 ) : 771-778.
  • 9TENTZERIS I, JARAI R, FARHAN S, et al. Complementary role of copeptin and high - sensitivity tmponin in predicting outcome in patients with stable chronic heart failure[J]. Eur J Heart Fail, 2011, 13(7): 726-733.
  • 10SHAMA UC, POKHAREL S, van BRAKEL TJ, et al. Galectin- 3 marks activated macrophages in failure- prone hypertrophied hearts and contributes to cardic dysfuntion[J]. Circulation, 2004, 110(19): 3121-3128.

引证文献17

二级引证文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部